Globus Medical, Inc. Financial Ratios — G2ME34 Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	23.81	22.07	15.98	17.49	17.34	13.49	11.93	14.53	11.99	7.03	9.19	10.6	4.2	2.52	12.29
Return on Assets (%)	20.4	19.02	13.54	14.57	14.67	11.85	10.7	13.15	10.96	6.37	8.2	9.43	3.43	1.99	10.19
Return on Capital (%)	23.56	22.06	15.9	17.38	17.21	13.22	11.46	13.51	10.9	7.03	9.19	10.58	3.86	2.23	11.44
Return on Invested Capital (%)	23.69	22.11	15.86	17.33	17.17	13.12	11.29	13.01	10.86	6.22	8.75	9.9	3.09	3.05	9.04
Gross Margin (%)	79.25	80.52	76.9	76.65	75.71	76.12	76.34	77.64	77.08	72.44	75.03	74.22	65.05	58.9	67.41
EBITDA Margin (%)	34.49	34.43	27.87	33.75	36.04	34.2	32.06	29.59	28.61	22.09	25.24	28.96	17.77	16.65	25.75
Operating Margin (%)	29.82	29.54	28.71	30.16	30.16	28.21	26.12	24.81	22.51	14.63	20.34	23.1	12.84	8.71	18.28
Incremental Operating Margin (%)	19.31	27.84	22.12	46.01	30.14	- -	9.72	13.98	- -	- -	46.96	63.94	- -	1.89	75.74
Pretax Margin (%)	29.25	29.7	23.48	29.23	31.72	27.89	26.72	26.45	24.19	15.96	18.83	23.76	10.54	4.79	20.59
Profit Margin (%)	18.34	19.13	15.79	19.5	20.7	18.5	16.88	21.95	19.76	12.96	15.57	18.59	7.83	4.09	18.3
Net Income to Common Margin (%)	18.34	19.13	15.79	19.5	20.7	18.5	16.88	21.95	19.76	12.96	15.57	18.59	7.83	4.09	18.3
Effective Tax Rate (%)	37.3	35.6	32.73	33.29	34.73	33.66	36.83	17.04	18.29	18.76	17.3	21.75	25.71	14.69	11.11
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	23.81	22.07	15.98	17.49	17.34	13.49	11.93	14.53	11.99	7.03	9.19	10.6	4.2	2.52	12.29

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	520	537	119
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	12	454	15
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	508	84	104
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.02	1.87	1.28	0.16
Net Debt/EBITDA	-1.25	-1.6	-0.74	-0.51	-0.31	-0.35	-0.58	-0.66	-0.87	-1.37	-0.8	-0.51	-0.18	-0.81	-0.7
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.03	3.91	3.24	0.25
Net Debt/EBIT	-1.47	-1.85	-0.88	-0.59	-0.35	-0.43	-0.73	-0.82	-1.14	-2.15	-1.12	-0.66	-0.37	-2.05	-1.1
EBITDA to Interest Expense	- -	-1,661.26	-259.25	-198.9	-150.54	-63.11	-30.86	-15.89	-12.91	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	-1,352.71	-208.54	-168.15	-111.62	-49.72	-23.09	-11.39	-8.85	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	-1,425.09	-267.08	-177.75	-126	-52.05	-25.14	-13.32	-10.15	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	-1	-1	-3	-7	-13	-17	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	85.74	86.44	83.41	83.21	85.76	89.7	89.73	91.15	91.54	89.69	88.97	88.93	78.61	79.54	86.24
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.19	12.72	2	2.27
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.19	11.25	1.77	2.21
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.17	10	1.59	1.96
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.33	13.02	12.86	2.59
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.32	11.52	11.39	2.53
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.29	10.23	10.23	2.24
Net Debt to Equity	-50.51	-54.95	-19.05	-14.05	-8.41	-8.05	-12.28	-11.78	-13.96	-15.89	-11.09	-8.15	-1.25	-8.17	-11.51
Net Debt/Capital (%)	-102.05	-122	-23.53	-16.35	-9.18	-8.75	-14	-13.35	-16.22	-18.9	-12.47	-8.84	-1.23	-8.68	-12.63
EBITDA	114	133	121	160	196	193	204	211	225	174	242	296	279	419	757
EBITDA-CapEx	92	108	97	135	146	152	153	151	154	111	185	222	200	304	582
Operating Income (Loss)	99	114	125	143	164	159	166	177	177	115	195	236	201	219	537

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.87	5.38	3.52	2.56	3.4	3.63	4.02	3.53	2.8	3.53	3.16	2.8	1.32	1.04	1.12
Current Ratio	8.84	9.11	6.13	5.26	6.59	6.43	6.67	6.56	6.17	6.8	6.17	6.18	4.88	2.54	4.26
Quick Ratio	6.58	6.86	4.48	3.47	4.44	4.83	5.38	5.03	4.25	4.76	4.35	4.17	2.61	1.72	2.61
CFO/Avg Current Liab	2.51	2.23	1.74	1.01	1.44	1.82	1.84	1.92	1.66	1.71	2.12	1.19	0.88	0.83	1.11
Common Equity/Total Assets	85.74	86.44	83.41	83.21	85.76	89.7	89.73	91.15	91.54	89.69	88.97	88.93	78.61	79.54	86.24
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.19	12.72	2	2.27
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.19	11.25	1.77	2.21
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.17	10	1.59	1.96
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.33	13.02	12.86	2.59
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.32	11.52	11.39	2.53
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.29	10.23	10.23	2.24
CFO/Total Liabilities	162.87	126.2	99.5	67.04	104.4	154.69	143.65	157.74	132.67	114.78	127.98	77.68	22.38	48.46	103.28
CFO/CapEx	3.4	3.1	3.95	3.2	2.44	3.61	3.1	3.04	2.43	3.12	4.86	2.41	3.11	4.51	4.32
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	17.75	6.52	8.61	11

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	7.44	7.7	7.5	6.88	7.12	6.65	6.1	5.62	5.39	5.33	6.26	5.42	4.38	4.75	4.75
Days Sales Outstanding	49.09	47.39	48.69	53.03	51.29	54.9	59.88	64.95	67.71	68.46	58.31	67.39	83.37	76.85	76.79
Inventory Turnover	1.56	1.37	1.51	1.37	1.35	1.24	1.36	1.33	1.1	1.02	1.03	0.98	0.96	1.37	1.35
Days Inventory Outstanding	234.11	266.18	241.28	265.75	270.59	295.28	268.2	274.38	332.16	357.06	355.62	370.9	381.9	265.67	270.28
Accounts Payable Turnover	10.95	9.46	8.58	7.73	7.88	8.5	6.88	7.16	9.7	11.69	12.3	11.22	23.66	12.85	12.16
Accounts Payable Turnover Days	33.33	38.57	42.56	47.22	46.34	42.94	53.08	51	37.62	31.22	29.66	32.53	15.43	28.41	30.01
Cash Conversion Cycle	249.86	275	247.41	271.55	275.54	307.24	275	288.33	362.26	394.3	384.27	405.76	449.84	314.11	317.06
Inventory to Cash Days	-185.02	-218.79	-192.59	-212.71	-219.29	-240.38	-208.32	-209.43	-264.45	-288.6	-297.31	-303.52	-298.54	-188.82	-193.49
Inventories	47	62	70	91	105	113	108	131	196	229	237	299	848	659	759
Raw Materials	2	2	1	9	12	13	20	21	33	40	42	60	103	122	162
Work In Process	2	2	3	2	7	11	10	13	16	16	17	19	37	46	64
Finished Goods	43	58	66	80	86	89	78	97	147	173	178	220	707	491	533
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,841	8,068	11,605	10,022
- Cash & Cash Equivalents	143	212	90	82	60	67	119	140	196	239	193	150	467	784	526
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	520	537	119
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,401	8,071	11,253	9,584
Total Capital	282	387	472	585	715	832	968	1,186	1,402	1,506	1,741	1,852	4,518	4,715	4,692
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.32	11.52	11.39	2.53
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.06	0.05	0.01
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.28	5.15	4.47	3.26
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.24	28.96	26.83	12.67
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.7	60.62	67.79	19.97
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30.26	33.14	21.61	12.72
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	51.73	48.85	27.77	16.55
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,984	6,784	11,643	12,196
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,544	6,786	11,290	11,758
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.72	7.38	10.21	10.61
TTM Sales	331	386	434	474	545	564	636	713	785	789	958	1,023	1,568	2,519	2,939
TTM EBITDA	114	133	121	160	196	193	204	211	225	174	242	296	279	419	757
TTM Operating Income	99	114	125	143	164	159	166	177	177	115	195	236	201	219	537
TTM Cash Flow to Firm	76	76	93	79	123	146	155	171	158	199	276	178	243	521	753
TTM Free Cash Flow to Firm	54	52	69	54	72	105	104	111	87	135	219	104	165	405	579

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	57.31	41.06	28.73	21.06
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.7	60.62	67.79	19.97
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,401	8,071	11,253	9,584
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.27	7.38	8.64	6.49
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.28	5.15	4.47	3.26
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.24	28.96	26.83	12.67
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30.8	54.46	111.3	22.37
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30.8	54.46	102.79	18.13
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30.8	54.46	115.44	23.93
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30.8	54.46	91.32	13.09
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.16	2.02	2.78	2.19
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.16	2.02	2.57	1.78
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.16	2.02	2.88	2.34
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.16	2.02	2.28	1.28
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.68	4.92	5.95	4.19
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.68	4.92	5.5	3.39
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.68	4.92	6.17	4.48
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.68	4.92	4.88	2.45
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.73	4.27	4.55	4.09
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.73	4.27	4.2	3.32
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.73	4.27	4.72	4.38
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.73	4.27	3.73	2.4
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.82	27.48	22.02	15.97
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.82	27.48	20.33	12.94
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.82	27.48	22.83	17.08
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.82	27.48	18.06	9.35
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	57.31	41.06	26.54	17.07
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	57.31	41.06	29.8	22.53
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	57.31	41.06	23.58	12.33
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.28	5.15	4.11	2.61
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.28	5.15	4.64	3.5
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.28	5.15	3.64	1.85
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.24	28.96	24.72	10.15
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.24	28.96	27.86	13.59
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.24	28.96	21.86	7.17
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.7	60.62	62.45	16.01
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.7	60.62	70.39	21.43
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.7	60.62	55.24	11.31
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.27	7.38	10.53	11.09
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.27	7.38	10.92	11.87
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,401	8,071	10,365	7,683
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,401	8,071	11,684	10,283
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,401	8,071	9,169	5,427

Shares Outstanding	725	732	749	760	765	769	775	791	801	800	814	804	1,094	1,102	903
Diluted Weighted Avg Shares	605	740	755	766	771	773	785	813	818	810	831	823	919	1,106	1,099
Basic Weighted Avg Shares	583	719	743	756	762	767	772	785	795	791	808	806	907	1,089	1,085
Revenue per Share	0.57	0.54	0.58	0.63	0.71	0.74	0.82	0.91	0.99	1	1.19	1.27	1.73	2.31	2.71
EBITDA per Share	0.2	0.18	0.16	0.21	0.26	0.25	0.26	0.27	0.28	0.22	0.3	0.37	0.31	0.39	0.7
Operating Income per Share	0.17	0.16	0.17	0.19	0.22	0.21	0.22	0.23	0.22	0.15	0.24	0.29	0.22	0.2	0.5
Basic EPS, GAAP	0.1	0.1	0.09	0.12	0.15	0.14	0.14	0.2	0.2	0.13	0.18	0.24	0.14	0.09	0.5
Basic EPS from Cont Ops	0.1	0.1	0.09	0.12	0.15	0.14	0.14	0.2	0.2	0.13	0.18	0.24	0.14	0.09	0.5
Diluted EPS, GAAP	0.1	0.1	0.09	0.12	0.15	0.13	0.14	0.19	0.19	0.13	0.18	0.23	0.13	0.09	0.49
Diluted EPS from Cont Ops	0.1	0.1	0.09	0.12	0.15	0.13	0.14	0.19	0.19	0.13	0.18	0.23	0.13	0.09	0.49
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.13	0.11	0.13	0.1	0.16	0.19	0.21	0.23	0.22	0.25	0.34	0.22	0.27	0.48	0.69
Free Cash Flow per Basic Share	0.09	0.07	0.09	0.07	0.1	0.14	0.14	0.16	0.13	0.17	0.27	0.13	0.18	0.37	0.53
Cash & Equivalents per Share	0.2	0.29	0.32	0.3	0.37	0.38	0.48	0.43	0.39	0.53	0.54	0.56	0.47	0.81	0.62
Book Value per Share	0.39	0.53	0.63	0.77	0.94	1.08	1.25	1.5	1.75	1.88	2.14	2.3	3.66	3.79	5.06
Tangible Book Value per Share	0.37	0.49	0.57	0.66	0.77	0.86	0.99	1.23	1.49	1.58	1.83	1.97	1.5	1.77	2.65

Globus Medical, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)